MedTrace Logo

Electronic Recording of Compliance With Occlusion Therapy for Amblyopia

NCT00131729 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-03-20

No results posted yet for this study

Summary

The purpose of this study was to determine whether compliance with occlusion therapy for amblyopia could be improved and, secondly, if risk factors for non-compliance could be identified.

Conditions

  • Amblyopia

Interventions

BEHAVIORAL

Educational programme

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Albert von Metzler Foundation

    collaborator OTHER

  • Augenstern Association, Germany

    collaborator UNKNOWN

  • Edith von Heyden Foundation, Germany

    collaborator UNKNOWN

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Huibert J Simonsz, MD, PhD · ErasmusMC, Department of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Completion
2005-12-31

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131729 on ClinicalTrials.gov